Sort
30,917 grants matching “tumor microenvironment”
Autologous CD19 Targeted 19-28z+ Tcells for the Treatment of Relapsed Diffuse Large B cell Lymphoma in Transplant Ineligible Elderly Patients
$313,752Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · P50 · FY2016 · CA
Targeting Stem-Cell Dependent Drug Resistance in Human MCL
$313,723Nami McCarty · University Of Texas Hlth Sci Ctr Houston · R01 · FY2016 · CA
Targeting Stem-Cell Dependent Drug Resistance in Human MCL
$313,723Nami McCarty · University Of Texas Hlth Sci Ctr Houston · R01 · FY2018 · CA
Targeting Stem-Cell Dependent Drug Resistance in Human MCL
$313,723Nami McCarty · University Of Texas Hlth Sci Ctr Houston · R01 · FY2015 · CA
Targeting Stem-Cell Dependent Drug Resistance in Human MCL
$313,723Nami McCarty · University Of Texas Hlth Sci Ctr Houston · R01 · FY2014 · CA
Targeting Stem-Cell Dependent Drug Resistance in Human MCL
$313,723Nami McCarty · University Of Texas Hlth Sci Ctr Houston · R01 · FY2017 · CA
Role of SHOX2 in breast tumor progression and metastasis
$313,671Shuang Huang · Augusta University · R01 · FY2014 · CA
Novel Immunotherapy of Glioma using miR-17-92 Transfected T Cells
$313,660Hideho Okada · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · NS
Interpretable deep learning models for translational medicine
$313,657Xinghua Lu · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · LM
Signaling in the ovarian cancer metastatic microenvironment
$313,652Jill Slack-Davis · University Of Virginia · R01 · FY2010 · CA
Innate anti-tumor immune responses
$313,592Jack D Bui · University Of California, San Diego · R01 · FY2011 · CA
Project 4: Modulating the natural killer cell response to oHSV1 in recurrent human GBM
$313,545Michael A Caligiuri · Brigham And Women'S Hospital · P01 · FY2022 · CA
Role of Hypoxia in the regulation of cancer cell differentiation
$313,500Zhong Yun · Yale University · R01 · FY2007 · CA
Administrative Core
$313,499Boyi Gan · University Of Tx Md Anderson Can Ctr · U54 · FY2023 · CA
Project 3: Effect of HTLV-1 Viral Oncogenes on the Bone Microenvironment in ATL
$313,489Katherine Nelson Weilbaecher · Ohio State University · P01 · FY2016 · CA
Targeting Ovarian Tumor Associated Myeloid Cells with Nanoparticles Therapeutics
$313,450Ronald J Buckanovich · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
Fibronectin Assembly, Structure and Function
$313,411Jean E Schwarzbauer · Princeton University · R01 · FY2007 · CA
Fibronectin Assembly, Structure and Function
$313,411Jean E Schwarzbauer · Princeton University · R01 · FY2009 · CA
Fibronectin Assembly, Structure and Function
$313,411Jean E Schwarzbauer · Princeton University · R01 · FY2008 · CA
Project 1: Mechanisms of Stiffening in Liver Cancer
$313,338Paul A Janmey · University Of Pennsylvania · U54 · FY2019 · CA
Cathepsins in Malignant Progression
$313,334Bonnie F Sloane · Wayne State University · R01 · FY2006 · CA
Multi-Scale Optical Imaging of the Cancer Vasculature and Tumor Microenvironment
$313,331Seok H Yun · University Of Texas Hlth Sci Ctr Houston · U54 · FY2009 · CA
The chemical biology of pharmacological ascorbate in cancer treatment
$313,325Garry R Buettner · University Of Iowa · R01 · FY2016 · CA
The chemical biology of pharmacological ascorbate in cancer treatment
$313,325Garry R Buettner · University Of Iowa · R01 · FY2017 · CA
Inflammation in Breast Cancer Initiation and Promotion
$313,325Kathryn L Schwertfeger · University Of Minnesota · R01 · FY2015 · CA